Literature DB >> 33708481

Quantification of myocardial deformation in patients with Fabry disease by cardiovascular magnetic resonance feature tracking imaging.

Lei Zhao1, Chen Zhang1, Jie Tian1, Madiha Saiedi2, Chenyao Ma3, Ning Li1, Fang Fang3, Xiaohai Ma4, Joseph Selvanayagam2.   

Abstract

BACKGROUND: Cardiac involvement is a major contributor of morbidity and mortality in Fabry disease (FD). Early detection and accurate evaluation of the disease progression is important in management. Cardiovascular magnetic resonance (CMR) derived feature fracking (FT) is a validated quantitative method of assessing myocardial deformation which may reflect early changes of myocardial function and track disease severity. We sought to evaluate the utility of CMR-FT as a measure of myocardial dysfunction in FD.
METHODS: Twenty FD patients (12 males, 40.8±14.9 years) and 20 age and sex matched healthy controls (10 males, 40.5±7.2 years) were prospectively enrolled. Subjects underwent CMR including cine, pre-/post-contrast T1 mapping and late gadolinium enhancement (LGE). FD patients were divided into three groups; group 1: patients without left ventricular hypertrophy (LVH) and LGE negative; group 2: patients with LVH positive, LGE either positive or negative; group 3: patients with LGE positive, LV wall thinning and heart failure. FT derived strain indices were measured and its associations with other processes were investigated.
RESULTS: In FD patients, 14 (70%) had LVH and 4 (20%) had LGE. Compared with normal controls, LV global longitudinal strain (GLS) were reduced significantly in all three Fabry groups (all P<0.05), global circumferential strain (GCS) were reduced only in group 2 and group 3 (P<0.05). Among three FD groups, there were significant differences of LV GLS, GCS, native T1 value and extracellular volume fraction (ECV) (all P<0.01), group 1 had mild LV strain indices impairment, group 3 had the most severe LV strain indices. When compared between FD subgroups, GLS and GCS showed significant difference between each two groups (all P<0.05). There were weak correlations between the LV functional parameters (ejection fraction, LV mass index), maximal wall thickness, T1 mapping indices (native T1, ECV) and LV strain indices. The strongest relation was between global longitudinal early diastolic strain rate and native T1 value (r=0.783, P<0.01).
CONCLUSIONS: CMR strain imaging identifies myocardial deformation in FD in different stages. Strain imaging can track disease severity and may be an alternative method for follow-up of FD patients. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Fabry disease (FD); T1 mapping; stage; strain indices

Year:  2021        PMID: 33708481      PMCID: PMC7944214          DOI: 10.21037/cdt-20-897

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  31 in total

1.  T₁ mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex.

Authors:  Richard B Thompson; Kelvin Chow; Aneal Khan; Alicia Chan; Miriam Shanks; Ian Paterson; Gavin Y Oudit
Journal:  Circ Cardiovasc Imaging       Date:  2013-08-06       Impact factor: 7.792

2.  Prognostic Significance of Cardiac Magnetic Resonance Imaging Late Gadolinium Enhancement in Fabry Disease.

Authors:  Kate Hanneman; Gauri R Karur; Syed Wasim; Chantal F Morel; Robert M Iwanochko
Journal:  Circulation       Date:  2018-11-27       Impact factor: 29.690

3.  Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study.

Authors:  Sabha Bhatti; Srikanth Vallurupalli; Stephanie Ambach; Adam Magier; Evan Watts; Vien Truong; Abdul Hakeem; Wojciech Mazur
Journal:  Int J Cardiovasc Imaging       Date:  2016-10-14       Impact factor: 2.357

4.  Impact of Myocardial Fibrosis on Left Ventricular Function Evaluated by Feature-Tracking Myocardial Strain Cardiac Magnetic Resonance in Competitive Male Triathletes With Normal Ejection Fraction.

Authors:  Enver Tahir; Jitka Starekova; Kai Muellerleile; Eric Freiwald; Alexandra von Stritzky; Julia Münch; Maxim Avanesov; Julius Matthias Weinrich; Christian Stehning; Ersin Cavus; Sebastian Bohnen; Ulf K Radunski; Stefan Blankenberg; Gerhard Adam; Perikles Simon; Axel Pressler; Monica Patten; Gunnar K Lund
Journal:  Circ J       Date:  2019-05-11       Impact factor: 2.993

5.  Global longitudinal strain, myocardial storage and hypertrophy in Fabry disease.

Authors:  Ravi Vijapurapu; Sabrina Nordin; Shanat Baig; Boyang Liu; Stefania Rosmini; Joao Augusto; Michel Tchan; Derralynn A Hughes; Tarekegn Geberhiwot; James C Moon; Richard Paul Steeds; Rebecca Kozor
Journal:  Heart       Date:  2018-10-03       Impact factor: 5.994

6.  Quantitative Myocardial Perfusion in Fabry Disease.

Authors:  Kristopher D Knott; Joao B Augusto; Sabrina Nordin; Rebecca Kozor; Claudia Camaioni; Hui Xue; Rebecca K Hughes; Charlotte Manisty; Louise A E Brown; Peter Kellman; Uma Ramaswami; Derralyn Hughes; Sven Plein; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2019-07-04       Impact factor: 7.792

7.  Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.

Authors:  Stephen Waldek; Manesh R Patel; Maryam Banikazemi; Roberta Lemay; Philip Lee
Journal:  Genet Med       Date:  2009-11       Impact factor: 8.822

8.  Reference ranges for three-dimensional feature tracking cardiac magnetic resonance: comparison with two-dimensional methodology and relevance of age and gender.

Authors:  Boyang Liu; Ahmed M Dardeer; William E Moody; Manvir K Hayer; Shanat Baig; Anna M Price; Francisco Leyva; Nicola C Edwards; Richard P Steeds
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-27       Impact factor: 2.357

9.  Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping.

Authors:  Daniel M Sado; Steven K White; Stefan K Piechnik; Sanjay M Banypersad; Thomas Treibel; Gabriella Captur; Marianna Fontana; Viviana Maestrini; Andrew S Flett; Matthew D Robson; Robin H Lachmann; Elaine Murphy; Atul Mehta; Derralynn Hughes; Stefan Neubauer; Perry M Elliott; James C Moon
Journal:  Circ Cardiovasc Imaging       Date:  2013-04-05       Impact factor: 7.792

10.  Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors.

Authors:  Maarten Arends; Marieke Biegstraaten; Derralynn A Hughes; Atul Mehta; Perry M Elliott; Daniel Oder; Oliver T Watkinson; Frédéric M Vaz; André B P van Kuilenburg; Christoph Wanner; Carla E M Hollak
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

View more
  2 in total

Review 1.  Cardiovascular magnetic resonance native T1 mapping in Anderson-Fabry disease: a systematic review and meta-analysis.

Authors:  Andrea Ponsiglione; Michele Gambardella; Roberta Green; Valeria Cantoni; Carmela Nappi; Raffaele Ascione; Marco De Giorgi; Renato Cuocolo; Antonio Pisani; Mario Petretta; Alberto Cuocolo; Massimo Imbriaco
Journal:  J Cardiovasc Magn Reson       Date:  2022-05-23       Impact factor: 6.903

2.  Myocardial Extracellular Volume Fraction Measured by Cardiac Magnetic Resonance Imaging Negatively Correlates With Cardiomyocyte Breadth in a Healthy Porcine Model.

Authors:  Shi-Jun Zhang; Di Chang; Ji-Yang Jin; Ya-Ling Wang; Lin Wang; Yuan-Cheng Wang; Zhen Wang; Shenghong Ju
Journal:  Front Cardiovasc Med       Date:  2022-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.